Ligand Reports Fourth Quarter and Full Year 2017 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. MDT
2. ENOV
3. AZN
4. BLSM
5. AON
6. GRMN
7. TXNM
8. YEXT
9. PTGX
10. AAPL

Go back to Ligand Reports Fourth Quarter and Full Year 2017 Financial Results
LIGAND PHARMA (NASDAQ: LGND) Delayed: 284.10 --0 (-0%)
Previous Close $284.10    52 Week High $139.79 
Open $284.10    52 Week Low $82.07 
Day High $284.10    P/E 660.70 
Day Low $284.10    EPS $0.43 
Volume 1,147